Status: Recruiting
REPRESENT-PF Registry
This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.
Participants needed: 275
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Vivek ReddyUpdated: Apr 17, 2026Locations: 2Duration: 12 Months
Eligibility criteria
All consecutive patients classified as racial or ethnic minorities undergoing ab... [+3]
Enrolled in an investigational drug or device clinical trial or any other trial... [+3]